The further along the company can get with a clinical trial on its own, the better bargaining position it's in.
Good clinical trial results will skyrocket the stock. I remind you that CYDY was at about 30 cents a year ago, was as high at 10 DOLLARS recently before the bear raid by Citron, and still it's above 6 dollars -- a huge return, if you bought at .30-5.00
I could see IPIX doing something similar
Good clinical trial results will skyrocket the stock. I remind you that CYDY was at about 30 cents a year ago, was as high at 10 DOLLARS recently before the bear raid by Citron, and still it's above 6 dollars -- a huge return, if you bought at .30-5.00
I could see IPIX doing something similar
6